Results 231 to 240 of about 17,033 (261)

Direct-acting antiviral agents for the treatment of HCV

Antiviral Therapy, 2012
Alexander J, Thompson, Stephen, Locarnini   +1 more
openaire   +2 more sources

Direct-acting antiviral treatment for hepatitis C

The Lancet, 2019
Jacinta A, Holmes, Stephanie M, Rutledge, Raymond T, Chung   +2 more
openaire   +2 more sources

Direct‐acting antivirals and recurrence of hepatocellular carcinoma

Liver Transplantation, 2017
Jorge A, Marrero, Amit G, Singal
openaire   +2 more sources

Direct acting antivirals

Reactions Weekly, 2019
openaire   +1 more source

[RESISTANCE OF HCV TO NEW DIRECT ACTING ANTIVIRALS].

Harefuah, 2016
Hepatitis C virus (HCV) is a leading cause of chronic viral hepatitis affecting 130-150 million people world-wide. HCV is an RNA virus of the Flaviviridae family, containing ~9600 nucleic acids coding for structural and nonstructural proteins, divided into 7 genotypes of which the most prevalent is genotype 1.
Yael, Gozlan, Ella, Mendelson, Ziv, Ben-Ari, Orna, Mor   +3 more
openaire   +1 more source

Direct-acting antiviral agents

Reactions Weekly, 2019
openaire   +1 more source

Pangenotypic Direct Acting Antivirals for the Treatment of Chronic Hepatitis C Virus Infection: A Systematic Literature Review and Meta-Analysis

EClinicalMedicine, 2020
Rita Morassut, Roger Chou, Ayesha Siddiqua   +2 more
exaly  

Treatment of Chronic Hepatitis C-Associated Cryoglobulinemia Vasculitis at the Era of Direct-Acting Antivirals

Therapeutic Advances in Gastroenterology, 2020
Cloé Comarmond, Patrice Cacoub, David Saadoun   +2 more
exaly  

Direct acting antiviral‐induced/exacerbated psoriasis: Addendum!

Dermatologic Therapy, 2019
Ayman Abdelmaksoud, Michelangelo Vestita
openaire   +2 more sources

The Oncologic Burden of Hepatitis C Virus Infection: A Clinical Perspective

Ca-A Cancer Journal for Clinicians, 2017
Felipe Samaniego, Nassim Hammoudi, Terri Lynn Shigle   +2 more
exaly